Diabetes mellitus is a leading cause of mortality and reduced life expectancy. We aim to estimate the burden of diabetes by type, year, regions, and socioeconomic status in 195 countries and territories over the past 28 years, which provide information to achieve the goal of World Health Organi...
These figures translate to 163.9-208.6 million adults with i-IFG worldwide. Despite this enormous burden of i-IFG, it is a highly understudied prediabetes phenotype with regard to the prevention of type 2 diabetes.Thirunavukkarasu SathishDepartment of Family and Preventive MedicineDiabetes care...
have suggested those with diabetes have a significantly greater risk of severe disease outcomes. The current large global burden of disease due to both COVID-19 and diabetes is likely to be a significant public health concern worldwide,
The burden of common urologic diseases, including benign prostatic hyperplasia (BPH), urinary tract infections (UTI), urolithiasis, bladder cancer, kidney cancer, and prostate cancer, varies both geographically and within specific regions. It is essential to conduct a comprehensive and precise assessment...
Our analysis of pooled global data showed that the use of either FPG or HbA1c alone might substantially underestimate the burden of diabetes relative to the number of people who would have elevated levels of either glycemic measure, especially in low- and middle-income countries where diagnosis ...
This year marked the launch of the Global Burden of Disease (GBD) 2021 study, the first presentation of the study to incorporate the devastating direct, and indirect, worldwide impacts from the COVID-19 pandemic on population health. Understanding how the study differs from its predecessors is ...
摘要: AimsThe prevalence of diabetes in China is among the highest in the world. For this reason, findings from the 2016 Global Burden of Disease (GBD) study were used to calculate the burden of hyperglycaemia and diabetes in China.
Theblood glucose monitoring devices marketsize is estimated to grow byUSD 8.71 billionat aCAGR of 9.45%between 2023 and 2028. The market is experiencing significant growth due to several key factors. The global burden of diabetes continues to rise, driving the demand for accurate and convenient ...
The prevalence of type 2 diabetes has been reaching epidemic proportions across the globe, affecting low/middle-income and developed countries. Two main contributors to this burden are the reduction in mortality from infectious conditions and concomitant
Cardiovascular disease(CVD)is the number one cause of mortality world-wide and places a high medical and socioeconomic burden on developing countries.Our understanding of CVD and its evolution over the last 100 years has altered considerably.Reasons for the increased rate of CVD in the developing ...